| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| HYDROXYPROGESTERONE CAPROATE
| HYDROXYPROGESTERONE CAPROATE | GENITO | INTRAMUSCULAR INJECTION SUBCUTANEOUS | Cmax 65 NANOMOLAR Tmax 110.4 HOUR HT 187.2 HOUR | PROGESTERONE RECEPTOR | PROGESTERONE RECEPTOR AGONIST CHEMBL208 PROGESTERONE RECEPTOR P06401 PROGESTERONE RECEPTOR HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3C NR3C3 | ANSM (in French) | |||
